Route 92 Medical’s FreeClimb 46 Catheter with Tenzing 4 Cleared by FDA 

September 28, 2026—Route 92 Medical, Inc. announced FDA 510(k) clearance for the FreeClimb 46 catheter with Tenzing 4. The two components are engineered as an integrated system to provide neurovascular access.

Rapid Medical’s Tigertriever 17 Ultra Receives CE Mark Approval for Stroke Treatment

September 25, 2026—Rapid Medical announced in a social media post that its Tigertriever 17 Ultra has received CE Mark approval, expanding its portfolio of adjustable clot retrievers for ischemic stroke.

Anaconda Closes Financing to Support ATHENA Trial of ANA Funnel Catheter

September 23, 2026—Anaconda Biomed, a developer of a portfolio of thrombectomy catheters based on its core funnel catheter technology platform, announced the closing of a $56 million financing round with participation from new and existing investors.

Dialybrid Commences FIH Trial for Silkothane AV Graft for Vascular Access in Hemodialysis

September 22, 2026—Italy-based Dialybrid S.r.l. announced commencement of the first-in-human (FIH) trial of the company’s arteriovenous (AV) graft for vascular access in hemodialysis.

Mölnlycke Launches Biogel Radiation Protection Gloves

September 22, 2026—Mölnlycke Health Care US, LLC. announced the launch of the company’s range of Biogel radiation protection gloves, designed to reduce clinician hand exposure to scattered radiation during fluoroscopy-guided, interventional, and other image-dependent procedures.

Piraeus Medical Launches FDA-Cleared 6-F 70 NeuGlide Catheter

September 18, 2026—Piraeus Medical, Inc. announced the United States launch and first clinical cases of the company’s 6-F 70 NeuGlide catheter, which has received FDA clearance.

Radiation Protection Device Developer Texray Appoints Dr. Ziv Haskal to Advisory Board

September 18, 2026—Texray AB announced that interventional radiologist Ziv J. Haskal, MD, has joined the company’s clinical and scientific advisory board. Texray, a developer of radiation protection textile, is based in Sweden with subsidiaries in the United States.

Pulnovo’s PADN-HF-PH Trial Results Presented and Published

September 18, 2026—Pulnovo Medical, a China-based developer of medical devices for pulmonary hypertension (PH) and heart failure (HF), announced that results from the PADN-HF-PH trial were presented at the European Society of Cardiology’s ESC Congress 2026 and simultaneously published by Hang Zhang, MD, et al in The New England Journal of Medicine.

GE HealthCare’s Photonova Spectra PCCT System Receives CE Mark Approval

September 17, 2026—GE HealthCare announced it has received CE Mark approval for Photonova Spectra, a photon-counting CT (PCCT) system with the company’s Deep Silicon detector technology.

Orchestra BioMed Receives Milestone Payment from Acquisition of Vivasure by Haemonetics

September 15, 2026—Orchestra BioMed Holdings, Inc. announced the receipt of $6.1 million on September 14, 2026, as the first milestone payment in connection with the acquisition of Vivasure Medical Limited by Haemonetics Corporation.